IRMD
IRadimedDAI scenario view
RankAlpha Sentiment AIAI sentiment snapshot
AI commentary
Consensus targets cluster near $98–$100, signaling mixed-to-neutral expectations with the median below the anchor [#SERP-4]. Short-term sentiment will hinge on earnings and contract news; concentrated ownership and target revisions can amplify moves [#SERP-1].
Evidence flagged
No evidence quality warning is currently attached to this memo.
AI events
Upcoming FY2025/Q4 results and any guidance revision could move price; no firm release date disclosed so conservatively set to 90 days out [#SERP-6].
New purchasing wins or broadened OR/MRI-suite adoption would materially lift revenue run-rate; timing tied to multi-quarter procurement cycles so use one-year horizon [#SERP-4].
Clinical study results or regulatory clarity that expands addressable market could trigger larger re-rating; assumed one-year horizon absent public timetable [#SERP-8].
Recommendation
No formal recommendation provided.

